Objective The UPAR gene encodes a pleiotropic receptor (urokinase-type plasminogen activator receptor [uPAR]) involved in fibrosis, immunity, angiogenesis, and vascular remodeling. Previous studies have implicated uPAR in systemic sclerosis (SSc) vasculopathy and impaired angiogenesis. We undertook this study to investigate whether UPAR gene promoter polymorphisms might be associated with SSc phenotypes in the European Caucasian population. Methods We studied a total population of 1,339 individuals. The Italian discovery cohort comprised 388 SSc patients and 391 healthy controls. The French replication cohort consisted of 344 SSc patients and 216 healthy controls. The UPAR rs344781 and rs4251805 single-nucleotide polymorphisms were genotype...
OBJECTIVE: To investigate the possible implication of SDF1-3' polymorphism in systemic sclerosis (S...
IntroductionA recent genome-wide association study (GWAS) comprising a French cohort of systemic scl...
OBJECTIVE: Pulmonary arterial hypertension (PAH) has emerged as a leading cause of death in systemi...
OBJECTIVE: The UPAR gene encodes a pleiotropic receptor (urokinase-type plasminogen activator recep...
Objective. The UPAR gene encodes a pleiotropic receptor (urokinase-type plasminogen activator recept...
International audienceIntroductionThe multifunctional nuclear receptor peroxisome proliferator-activ...
: Systemic sclerosis (SSc)-related pulmonary arterial hypertension (PAH) has emerged as a major mort...
Abstract INTRODUCTION: Systemic sclerosis (SSc)-related pulmonary arterial hypertension (PAH) has em...
Introduction Systemic sclerosis (SSc)-related pulmonary arterial hypertension (PAH) has emerged as a...
INTRODUCTION: Systemic sclerosis (SSc)-related pulmonary arterial hypertension (PAH) has emerged as...
Introduction: Systemic sclerosis (SSc)-related pulmonary arterial hypertension (PAH) has emerged as ...
Introduction Systemic sclerosis (SSc)-related pulmonary arterial hypertension (PAH) has emerged as a...
ABSTRACT Introduction Systemic sclerosis (SSc)-related pulmonary arterial hypertension (PAH) has e...
Objective To investigate whether polymorphisms in Toll-like receptor (TLR) genes, previously reporte...
OBJECTIVE: To investigate whether polymorphisms in Toll-like receptor (TLR) genes, previously report...
OBJECTIVE: To investigate the possible implication of SDF1-3' polymorphism in systemic sclerosis (S...
IntroductionA recent genome-wide association study (GWAS) comprising a French cohort of systemic scl...
OBJECTIVE: Pulmonary arterial hypertension (PAH) has emerged as a leading cause of death in systemi...
OBJECTIVE: The UPAR gene encodes a pleiotropic receptor (urokinase-type plasminogen activator recep...
Objective. The UPAR gene encodes a pleiotropic receptor (urokinase-type plasminogen activator recept...
International audienceIntroductionThe multifunctional nuclear receptor peroxisome proliferator-activ...
: Systemic sclerosis (SSc)-related pulmonary arterial hypertension (PAH) has emerged as a major mort...
Abstract INTRODUCTION: Systemic sclerosis (SSc)-related pulmonary arterial hypertension (PAH) has em...
Introduction Systemic sclerosis (SSc)-related pulmonary arterial hypertension (PAH) has emerged as a...
INTRODUCTION: Systemic sclerosis (SSc)-related pulmonary arterial hypertension (PAH) has emerged as...
Introduction: Systemic sclerosis (SSc)-related pulmonary arterial hypertension (PAH) has emerged as ...
Introduction Systemic sclerosis (SSc)-related pulmonary arterial hypertension (PAH) has emerged as a...
ABSTRACT Introduction Systemic sclerosis (SSc)-related pulmonary arterial hypertension (PAH) has e...
Objective To investigate whether polymorphisms in Toll-like receptor (TLR) genes, previously reporte...
OBJECTIVE: To investigate whether polymorphisms in Toll-like receptor (TLR) genes, previously report...
OBJECTIVE: To investigate the possible implication of SDF1-3' polymorphism in systemic sclerosis (S...
IntroductionA recent genome-wide association study (GWAS) comprising a French cohort of systemic scl...
OBJECTIVE: Pulmonary arterial hypertension (PAH) has emerged as a leading cause of death in systemi...